Virendra Bhandari Professor, Department of Radiation Oncology, Sri Aurobindo Medical College and Institute, Indore 453555, Madhya Pradesh, India
Pragati Kesharwani Resident, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore 453555, Madhya Pradesh, India
Somya Sharma Resident, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore 453555, Madhya Pradesh, India
Saloni Singhal Resident, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore 453555, Madhya Pradesh, India
Ashar Iqbal Lodi Assistant Professor, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore 453555, Madhya PradesH, India
Address for correspondence: Virendra Bhandari, Professor, Department of Radiation Oncology, Sri Aurobindo Medical College and Institute, Indore 453555, Madhya Pradesh, India E-mail: virencancer@yahoo.co.in
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Pragati Kesharwani, Somya Sharma, Saloni Singhal et. al. Biphenotypic Sinonasal Sarcoma: A Rare Case Report/Ind J Canc Educ Res 2024;12(1):27-30.
Timeline
Received : July 18, 2023
Accepted : September 01, 2023
Published : June 25, 2024
Abstract
Background: Biphenotypic Sinonasal Sarcoma (BSNS) is a recently described tumor with its site of origin limited to the nose and paranasal sinus. It is a rare low-grade sarcoma characterized by concomitant neural and myogenic differentiation with high recurrence rates but lacks metastatic potential. Limited literature is available about the standard treatment regimens due to their rarity. Case Presentation: Herein we describe the details of the case of a 55-year-old male, known case of recurrent biphenotypic sinonasal Sarcoma who presented with bilateral nasal obstruction. The diagnosis was confirmed by immunohistochemistry. He underwent surgery but developed recurrence twice, and later treated with Radiation Therapy. Conclusions: Mainstay of the treatment remains surgery but due to its rarity, no definite treatment guidelines are defined. Radica or adjuvant treatment with chemotherapy and/or radiotherapy have been tried with limited data on the outcome.
References
1. Lewis JT, Oliveria AM, Nascimento AG, Schembri - Wismayer D, Moore EA, Olsen KD, et al. Low - grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. The American journal of surgical pathology. 2012; 36(4): 517-25.
2. Agaimy a, Haller F, Hartmann A. Sinonasal tumors: News from the WHO with special reference to mesenchymal entities. Pathologe. 2018; 39(1).
3. Connan R, Wiggins R, Witt B, Dundar Y, Johnston T, Hunt J. Imaging and Outcomes for a New Entity: Low - Grade Sinonasal Sarcoma with Neural and Myogenic Features. Journal of Neurological Surgery Reports. 2017; 78(01): 15-19.
4. Chitguppi C, Koszewski I, Collura K, Curtis M, Nyquist G, Rabinowitz M, et al. Addendum: Biphenotypic Sinonasal Sarcoma—Case Report and Review of Clinicopathological Features and Diagnostic Modalities. Journal of Neurological Surgery Part B: Skull Base. 2019.
5. Wang X, Bledsoe KL, Graham RP, Asmann YW, Viswanatha DS, Lewis JE, et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nature Genetics. 2014; 46(7): 666-668.
6. Kominsky E, Boyke AE, Madani D, Kamat A, Schiff BA, Agarwal V. Biphenotypic Sinonasal Sarcoma: A Case Report and Review of Literature. Ear, Nose and Throat Journal. 2021.
7. Le Loarer F, Laffont S, Lesluyes T, Triode F, Antonescu C, ucile ACD, et al. Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum. American Journal of Surgical Pathology. 2019; 43(6): 747-754.
8. Bell D, Phan J, DeMonte F, Hanna EY. High-Grade Transformation of Low - Grade Biphenotypic Sinonasal Sarcoma: A Morphological, Immunohistochemical, and Molecular Study. In 31st Annual Meeting North American Skull Base Society; 2022.
9. Lin Y, Liao B, Han A. Biphenotypic sinonasal sarcoma with diffuse infiltration and intracranial extension: A case report. International Journal of Clinical and Experimental Pathology. 2017; 10(12).
10. Rooper LM, Huang SC, Antonescu CR, Westra WH, Bishop JA. Biphenotypic sinonasal sarcoma: An expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression. Human Pathology. 2016; 55.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Pragati Kesharwani, Somya Sharma, Saloni Singhal et. al. Biphenotypic Sinonasal Sarcoma: A Rare Case Report/Ind J Canc Educ Res 2024;12(1):27-30.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Description: IHC markers positive for Caldesmol, S-100, SMA and Ki 67 proliferative index 10%
Heading
Description: MRI face + Neck with contrast showing lesion involving bilateral nasal cavities, ethmoid air cells, protruding posteriorly
into the nasopharynx and anteroposteriorly extending into the right frontal sinuses